Komori
Kanemitsu (7208) · RiskRestated

Delays in the Development of New Products and Technologies

First written in FY2016. 20 of 22 entries say "Restated". Latest entry: FY2026-H1.

22entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2021-Q3RestatedFY2022-Q1 – FY2026-H12016: 320162017: 320172018: 320182019: 320192020: 120202021: 420212022: 120222023: 220232024: 120242025: 12025
Same theme, other companies
Risk of Delayed New Product Launches Due to R&D DelaysA theme 80 companies write about · 80 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 3 of 24 companies on the "Worse" side.

50 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 80 companies compared. The sentences above are computed from all 80.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the interim consolidated accounting period, no new business or other risks arose. There were also no significant changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  2. FY2025-H1RestatedAnnual report

    「During the interim consolidated accounting period, no new business or other risks arose. There were also no significant changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  3. FY2024-Q1RestatedAnnual report

    「During the first quarter, no new business or other risks arose. There were also no significant changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  4. FY2023-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  5. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  6. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the 2nd quarter cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  7. FY2022-Q1RestatedAnnual report

    「During the first quarter, no new business or other risks arose. There were also no significant changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no new occurrences or material changes concerning the risk of delays in developing new products and technologies.
  8. FY2021MitigatedAnnual report

    「The Group is working to enhance its new product development capabilities and shorten development times through the active use of the simulation prototype development system KAVS (Kanemitsu Virtual Analysis Simulation), which has been introduced at its Research Center and Thailand Technical Center.」

    The Company identifies enhanced development capabilities and shorter development times through the active use of KAVS as measures to address the risk of delays in new product development.
  9. FY2021-Q3RestatedAnnual report

    「No new business or other risks arose during the third-quarter cumulative consolidated period.」

    No new changes are indicated concerning the risk of delays in developing new products and technologies.
  10. FY2020-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  11. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  12. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  13. FY2019-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  14. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  15. FY2019-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  16. FY2018-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  17. FY2018-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  18. FY2018-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  19. FY2017-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  20. FY2017-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  21. FY2017-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The Company states that there have been no material changes concerning the risk of delays in developing new products and technologies.
  22. FY2016First statedAnnual report

    「However, new product development is inherently uncertain, and delays in developing new products or technologies that meet market needs may affect the Group's operating results and financial condition.」

    The delay risk in developing new products and technologies is described as a remaining risk despite the Group having development centers.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kanemitsu yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.